- Home
- ABCL vs SBGI Comparison
ABCL vs SBGI Comparison
Compare ABCL & SBGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABCL
- SBGI
- Stock Information
- Founded
- ABCL 2012
- SBGI 1986
- Country
- ABCL Canada
- SBGI United States
- Employees
- ABCL N/A
- SBGI N/A
- Industry
- ABCL Biotechnology: Pharmaceutical Preparations
- SBGI Broadcasting
- Sector
- ABCL Health Care
- SBGI Industrials
- Exchange
- ABCL Nasdaq
- SBGI Nasdaq
- Market Cap
- ABCL 1.1B
- SBGI 886.6M
- IPO Year
- ABCL 2020
- SBGI 1995
- Fundamental
- Price
- ABCL $3.61
- SBGI $15.76
- Analyst Decision
- ABCL Buy
- SBGI Buy
- Analyst Count
- ABCL 5
- SBGI 5
- Target Price
- ABCL $7.75
- SBGI $21.00
- AVG Volume (30 Days)
- ABCL 5.2M
- SBGI 583.8K
- Earning Date
- ABCL 11-06-2025
- SBGI 11-05-2025
- Dividend Yield
- ABCL N/A
- SBGI 6.33%
- EPS Growth
- ABCL N/A
- SBGI N/A
- EPS
- ABCL N/A
- SBGI N/A
- Revenue
- ABCL $35,325,000.00
- SBGI $3,337,000,000.00
- Revenue This Year
- ABCL $16.99
- SBGI N/A
- Revenue Next Year
- ABCL $62.91
- SBGI $9.50
- P/E Ratio
- ABCL N/A
- SBGI N/A
- Revenue Growth
- ABCL 7.17
- SBGI N/A
- 52 Week Low
- ABCL $1.89
- SBGI $11.89
- 52 Week High
- ABCL $6.52
- SBGI $18.46
- Technical
- Relative Strength Index (RSI)
- ABCL 33.35
- SBGI 56.96
- Support Level
- ABCL $3.33
- SBGI $14.52
- Resistance Level
- ABCL $3.83
- SBGI $16.22
- Average True Range (ATR)
- ABCL 0.27
- SBGI 0.75
- MACD
- ABCL -0.01
- SBGI -0.08
- Stochastic Oscillator
- ABCL 34.30
- SBGI 37.80
About ABCL AbCellera Biologics Inc.
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.
About SBGI Sinclair Inc.
Sinclair Inc. is the owner-operator of the second largest portfolio of television stations in the United States, with 185 full power stations in 86 markets, covering 40% of US households. Of the firm's roughly 600 channels, 150 are affiliated with the four national broadcasters—Fox, ABC, CBS, and NBC—with over 80 other channels aligned with The CW (Nexstar) and MyNetworkTV (Fox). Sinclair owns the Tennis Channel and stakes in Marquee Sports Network and YES Network, providing their premium sports content to pay-TV distributors.